Erratum: Targeting the NLRP3 inflammasome in inflammatory diseases

被引：21
|
作者：
Matthew S. J. Mangan
Edward J. Olhava
William R. Roush
H. Martin Seidel
Gary D. Glick
Eicke Latz
机构：
来源：
Nature Reviews Drug Discovery | 2018年 / 17卷 / 9期
关键词：
D O I：
10.1038/nrd.2018.149
中图分类号：
学科分类号：
摘要：
Nature Reviews Drug Discovery 17, 588–606 (2018) A sentence mentioning the authors of reference 122 has been amended to include both corresponding authors.
引用
收藏
页码：688 / 688
相关论文
共 50 条
  • [41] NLRP3 Inflammasome and Inflammatory Bowel Disease
    Zhen, Yu
    Zhang, Hu
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [42] NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
    Mezzaroma, Eleonora
    Abbate, Antonio
    Toldo, Stefano
    MOLECULES, 2021, 26 (04):
  • [43] Inflammatory Bowel Disease and the NLRP3 Inflammasome
    Kanneganti, Thirumala-Devi
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07): : 694 - 696
  • [44] A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
    Coll, Rebecca C.
    Robertson, Avril A. B.
    Chae, Jae Jin
    Higgins, Sarah C.
    Munoz-Planillo, Raul
    Inserra, Marco C.
    Vetter, Irina
    Dungan, Lara S.
    Monks, Brian G.
    Stutz, Andrea
    Croker, Daniel E.
    Butler, Mark S.
    Haneklaus, Moritz
    Sutton, Caroline E.
    Nunez, Gabriel
    Latz, Eicke
    Kastner, Daniel L.
    Mills, Kingston H. G.
    Masters, Seth L.
    Schroder, Kate
    Cooper, Matthew A.
    O'Neill, Luke A. J.
    NATURE MEDICINE, 2015, 21 (03) : 248 - +
  • [45] The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases
    Zhao, Shizhen
    Li, Xiaotian
    Wang, Jie
    Wang, Honggang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [46] Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
    Vong, Chi Teng
    Tseng, Hisa Hui Ling
    Yao, Peifen
    Yu, Hua
    Wang, Shengpeng
    Zhong, Zhangfeng
    Wan, Yitao
    DRUG DISCOVERY TODAY, 2021, 26 (06) : 1394 - 1408
  • [47] A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
    Rebecca C Coll
    Avril A B Robertson
    Jae Jin Chae
    Sarah C Higgins
    Raúl Muñoz-Planillo
    Marco C Inserra
    Irina Vetter
    Lara S Dungan
    Brian G Monks
    Andrea Stutz
    Daniel E Croker
    Mark S Butler
    Moritz Haneklaus
    Caroline E Sutton
    Gabriel Núñez
    Eicke Latz
    Daniel L Kastner
    Kingston H G Mills
    Seth L Masters
    Kate Schroder
    Matthew A Cooper
    Luke A J O'Neill
    Nature Medicine, 2015, 21 : 248 - 255
  • [48] The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
    Blevins, Hallie M.
    Xu, Yiming
    Biby, Savannah
    Zhang, Shijun
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [49] Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases
    Ren, Guang-Ming
    Li, Jian
    Zhang, Xiao-Chun
    Wang, Yu
    Xiao, Yang
    Zhang, Xuan-Yi
    Liu, Xian
    Zhang, Wen
    Ma, Wen-Bing
    Zhang, Jie
    Li, Ya-Ting
    Tao, Shou-Song
    Wang, Ting
    Liu, Kai
    Chen, Hui
    Zhan, Yi-Qun
    Yu, Miao
    Li, Chang-Yan
    Ge, Chang-Hui
    Tian, Bo-Xue
    Dou, Gui-Fang
    Yang, Xiao-Ming
    Yin, Rong-Hua
    SCIENCE IMMUNOLOGY, 2021, 6 (58)
  • [50] Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors
    Lou, Shengying
    Wu, Miaolian
    Cui, Sunliang
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (15) : 2021 - 2051
12345